Alloy Therapeutics, Inc.
also invests · investor profileWaltham, US · Founded 2020 · Delaware corporation · 5 known investors
A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies. It gives its portfolio companies access to Alloy's discovery technologies and enabling services, and support in strategy, legal, R&D funding, and partnerships to reach Series A financing.
BiotechDeep Tech
Founders & leadership
Alloy Therapeutics, Inc. was founded in 2020 by Errik B. Anderson.
EB
PB
Piotr BobrowiczExecutive
JR
Jay RosanelliExecutive
Board
AS
Anthony SunBoard director
AH
Alaa HalawaBoard director
UN
JC
Jason CammBoard director
CK
Christian KanadyBoard director
AK
LS
Logan SnyderBoard director
FH
Fabian HansenBoard director
JC
Jason ColomaBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$146.8M disclosed across 3 rounds · 2021–2026
▶$30MraisedApr 2026 · 11 investors · BiotechnologyRule 506(b)
▶$30MraisedApr 2026 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony SunDirector
- Alaa HalawaDirector
- Ulrik NielsenDirector
- Jason CammDirector
- Jason ColomaDirector
- Christian KanadyDirector
- Alex KolicichDirector
- Errik B. AndersonExecutive Officer, Director
- Piotr BobrowiczExecutive Officer, Director
- Logan SnyderDirector
- Offering amount
- $40M
- Amount sold
- $30M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.7MraisedOct 2022 · 13 investors · BiotechnologyRule 506(b)
▶$41.7MraisedOct 2022 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony SunDirector
- Alaa HalawaDirector
- Ulrik NielsenDirector
- Piotr BobrowiczExecutive Officer, Director
- Jason CammDirector
- Errik B. AndersonExecutive Officer, Director
- Logan SnyderExecutive Officer, Director
- Fabian HansenDirector
- Alex KolicichDirector
- Jason ColomaDirector
- Offering amount
- $41.7M
- Amount sold
- $41.7M
- Proceeds to insiders
- $1M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$75MraisedApr 2021 · 17 investors · BiotechnologyRule 506(b)
▶$75MraisedApr 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Piotr BobrowiczExecutive Officer, Director
- Ulrik NielsenDirector
- Jay RosanelliExecutive Officer
- Jason ColomaDirector
- Errik B. AndersonExecutive Officer, Director
- Fabian HansenDirector
- Jason CammDirector
- Alex KolicichDirector
- Logan SnyderExecutive Officer, Director
- Offering amount
- $75M
- Amount sold
- $75M
- Proceeds to insiders
- $1M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Alloy Therapeutics, Inc. went on to found or lead other companies.
In the news
Frequently asked questions
- What does Alloy Therapeutics, Inc. do?
- A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies. It gives its portfolio companies access to Alloy's discovery technologies and enabling services, and support in strategy, legal, R&D funding, and partnerships to reach Series A financing.
- Who founded Alloy Therapeutics, Inc.?
- Alloy Therapeutics, Inc. was founded by Errik B. Anderson in 2020.
- Who are Alloy Therapeutics, Inc.'s investors?
- Alloy Therapeutics, Inc.'s investors include 82VS, 8VC, JIC Venture Growth Investments, MC Healthcare Ventures, Mission Biocapital.
- How much funding has Alloy Therapeutics, Inc. raised?
- Alloy Therapeutics, Inc. has disclosed $146.8M raised across 3 rounds.
- Where is Alloy Therapeutics, Inc. headquartered?
- Alloy Therapeutics, Inc. is headquartered in Waltham, US.